SCHEMBL18852827

SCHEMBL18852827

c1ccc2c(c1)ccc1oc3c(-n4c5ccccc5c5ccccc54)nc(-n4c5ccccc5c5ccccc54)nc3c12

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TDP1 Q9NUW8 2/20 0.35
▸ L3MBTL1 Q9Y468 1/20 0.35
▸ PRKDC P78527 3/20 0.34
▸ XRCC6 P12956 1/20 0.34
▸ XRCC5 P13010 1/20 0.34
▸ MAPT P10636 3/20 0.33
▸ CYP1A2 P05177 3/20 0.33
▸ TSHR P16473 3/20 0.33
▸ KDM4E B2RXH2 2/20 0.33
▸ MEN1 O00255 2/20 0.33
▸ HPGD P15428 2/20 0.33
▸ KMT2A Q03164 2/20 0.33
▸ ALDH1A1 P00352 1/20 0.33
▸ CYP3A4 P08684 1/20 0.33
▸ GAA P10253 1/20 0.33
▸ LMNA P02545 1/20 0.33
▸ AHR P35869 3/20 0.33
▸ ABCG2 Q9UNQ0 2/20 0.33
▸ CYP1A1 P04798 1/20 0.33
▸ FYN P06241 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26741774 0.84 CREBBP (0.31) TDP1L3MBTL1HSD17B10CREBBP
SCHEMBL16905906 0.83 ALDH1A1 (0.46) MAPTTSHRKDM4EMEN1HPGD
SCHEMBL18852825 0.83 KMT2A (0.35) TDP1L3MBTL1PRKDCXRCC6XRCC5
SCHEMBL18852833 0.82 HSD17B10 (0.36) L3MBTL1PRKDCXRCC6XRCC5MAPT
SCHEMBL18852822 0.81 KDM4E (0.32) L3MBTL1CYP1A2TSHRKDM4EMEN1
SCHEMBL22652260 0.81 TDP1 (0.37) TDP1L3MBTL1MAPTCYP1A2TSHR
SCHEMBL20024406 0.80 HSD17B10 (0.37) L3MBTL1MAPTTSHRKDM4EMEN1
SCHEMBL26742388 0.78 TSHR (0.44) MAPTCYP1A2TSHRKDM4EMEN1
SCHEMBL26742347 0.78 TSHR (0.42) L3MBTL1MAPTCYP1A2TSHRKDM4E
SCHEMBL23077196 0.78 TSHR (0.34) MAPTCYP1A2TSHRKDM4EMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10680190-B2 Organic compound, organic optoelectronic element, and display device SAMSUNG SDI CO., LTD. (KR) 2020-06-09 — — US disclosed
US-20170141331-A1 ORGANIC COMPOUND, ORGANIC OPTOELECTRONIC ELEMENT, AND DISPLAY DEVICE SAMSUNG SDI CO.,LTD. (KR) 2017-05-18 — — US disclosed
US-20170141331-A1 ORGANIC COMPOUND, ORGANIC OPTOELECTRONIC ELEMENT, AND DISPLAY DEVICE SAMSUNG SDI CO.,LTD. (KR) 2017-05-18 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170141331-A1 ORGANIC COMPOUND, ORGANIC OPTOELECTRONIC ELEMENT, AND DISPLAY DEVICE OCIAD1, OXER1, OCIAD2 TDP1 2165/4885L3MBTL1 3198/4885PRKDC 2968/4885
US-10680190-B2 Organic compound, organic optoelectronic element, and display device OCIAD1, OXER1, OCIAD2 TDP1 2165/4885L3MBTL1 3198/4885PRKDC 2968/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback